Ítem
Acceso Abierto
Guillain-Barré syndrome in Colombia: where do we stand now?
Título de la revista
Autores
Mahecha, María P.
Ojeda, Ernesto
Vega, Daniel A.
Sarmiento Monroy, Juan C.
Anaya, Juan-Manuel
Archivos
Fecha
2016-07-15
Directores
ISSN de la revista
Título del volumen
Editor
Springer Nature
Buscar en:
Métricas alternativas
Resumen
Abstract
Guillain–Barre´ syndrome (GBS) is a rapid-onset muscle weakness disease caused by the immune-mediated damage of the peripheral nervous system. Since there is an increase incidence of GBS cases in Latin America, particularly in Colombia, and most of them are currently preceded by Zika virus (ZIKV) infection, we aimed to assess the available evidence of the disease in Colombia through a systematic literature review. Out of 51 screened abstracts, only 16 corresponded to articles that met inclusion criteria, of which 15 were case reports or case series. A total of 796 cases of GBS were reported in the included articles. The majority of patients were males (66.8 %) and younger than 50 years old (94 %). An infectious disease before the onset of GBS was registered in 31 % of patients, with gastrointestinal or respiratory symptoms being the most frequently observed. In those cases in which electrodiagnostic tests were performed, the most common subphenotype was acute inflammatory demyelinating polyneuropathy (17 %). Death was reported in 15 % of patients. Data regarding GBS in Colombia is scant and heterogeneous. Taking into account the burden of the disease and the recent rise of GBS cases associated with ZIKV, a careful patient evaluation and a systematic collection of data are warranted. A form to data gathering is proposed.
Palabras clave
Keywords
Guillain–Barre´ syndrome , Zika virus , Anti-gangliosides antibodies , Latin America
